This study investigates a chronic pain management program that includes immersive virtual reality (VR) and medication tapering for adults with chronic non-cancer pain. Chronic pain is long-lasting pain that persists beyond the usual recovery period or is associated with a chronic health condition. The purpose of this study is to explore the effectiveness of combining VR with psychoeducation, physical activation, and emotional regulation techniques as part of a broader pain management strategy.

Participants in the study will be randomly assigned to either an intervention group or a control group. The intervention group will receive the full REDOCVR program, which includes the use of VR to enhance engagement and support therapeutic learning, along with physician-supervised medication tapering. The control group will receive standard educational materials and usual care. The study will measure outcomes such as changes in medication use, emotional well-being, anxiety, depression, and quality of life.

• Who can participate: Adults aged 18 and older with chronic non-cancer pain lasting at least 3 months are eligible. Participants must be assigned to a participating primary care center and show symptoms such as central sensitization or emotional distress. They must also be able to provide informed consent and complete questionnaires.
• Study details: Participants will be involved in a program that includes immersive virtual reality as a tool to enhance engagement in their treatment. They will also receive support for tapering off medications under a physician's guidance. The control group will continue with usual care and receive standard educational materials. A placebo is not used in this study.